These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7513363)

  • 1. An evaluation of serum and tissue bound immunoglobulins in prostatic diseases.
    Gahankari DR; Golhar KB
    J Postgrad Med; 1993; 39(2):63-7. PubMed ID: 7513363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Zinc levels in prostatic fluid of patients with prostate pathologies].
    Gómez Y; Arocha F; Espinoza F; Fernández D; Vásquez A; Granadillo V
    Invest Clin; 2007 Sep; 48(3):287-94. PubMed ID: 17853788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
    Goel T; Garg S
    Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis, and adenocarcinoma.
    Anderson RU; Fair WR
    Invest Urol; 1976 Sep; 14(2):137-40. PubMed ID: 61187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of estrogen receptor beta in benign prostatic hyperplasia complicated by chronic prostatitis].
    Yang GQ; Li SW; Zheng H; Zhang WB; Hu WL; Zheng XM
    Zhonghua Nan Ke Xue; 2009 Apr; 15(4):314-7. PubMed ID: 19472903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K channel expression in prostate epithelium and its implications in men with chronic prostatitis.
    Liang CZ; Guo QK; Hao ZY; Yang S; Wang DB; Wu LX; Liu C; Wang KX; Zhang XJ
    BJU Int; 2006 Jan; 97(1):190-2. PubMed ID: 16336354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
    Sasor A; Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of chronic bacterial prostatitis on changes in concentration and free and total prostatic specific antigen in the serum and urine from patients with benign prostatic hyperplasia and prostatic cancer].
    Mazo EB; Grigor'ev ME; Stepenskiĭ AB
    Urologiia; 2001; (5):3-7. PubMed ID: 11641977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological review of prostatic diseases in Kano, Nigeria.
    Mohammed AZ; Alhassan SU; Edino ST; Ochicha O
    Niger Postgrad Med J; 2003 Mar; 10(1):1-5. PubMed ID: 12717456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of serum immunoglobulins from patients with non-neoplastic prostates and prostatic carcinoma.
    Deture FA; Deardourff SL; Kaufman HE; Centifanto YM
    J Urol; 1978 Oct; 120(4):435-7. PubMed ID: 81321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate.
    Dema A; Tudose N
    Rom J Morphol Embryol; 1998; 44(1-4):93-100. PubMed ID: 15678849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
    Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
    Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grading of the prostate carcinoma: cyto-histological correlations on 100 cases.
    Dalla Palma P; Dante S; Costantin G; Rebuffi A; Zattoni F; Piazza R
    Histol Histopathol; 1986 Oct; 1(4):399-402. PubMed ID: 2485167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation.
    Wang W; Bergh A; Damber JE
    APMIS; 2009 Mar; 117(3):185-95. PubMed ID: 19245591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma.
    Mohler JL; Chen Y; Hamil K; Hall SH; Cidlowski JA; Wilson EM; French FS; Sar M
    Clin Cancer Res; 1996 May; 2(5):889-95. PubMed ID: 9816246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Benign mimickers of prostatic adenocarcinoma: diagnostic features and differential diagnosis].
    Cheng L; Huang W; Li Y; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):52-8. PubMed ID: 24713255
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship of platelet-derived growth factor with benign prostatic hyperplasia].
    Chu J; Zhong HX
    Zhonghua Nan Ke Xue; 2007 Oct; 13(10):932-5. PubMed ID: 17977330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
    Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc in normal and pathological human prostate gland.
    Bataineh ZM; Bani Hani IH; Al-Alami JR
    Saudi Med J; 2002 Feb; 23(2):218-20. PubMed ID: 11938400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.